Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer
收藏DataMed2026-07-12 收录
官方服务：
资源简介：
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients who have recurrent or refractory small cell lung cancer.
提供机构：
ClinicalTrials.gov
